Arizona State Retirement System Amgen Inc Transaction History

Arizona State Retirement System

$14.3 Billion
Q1 2024

A detailed history of Arizona State Retirement System transactions in Amgen Inc stock. As of the latest transaction made, Arizona State Retirement System holds 153,579 shares of AMGN stock, worth $48 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

153,579

Previous 150,491 2.05%

Holding current value

$48 Million

Previous $43.3 Million 0.74%

% of portfolio

0.31%

Previous 0.33%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $830,270 - $1 Million	3,088 Added 2.05%	153,579 $43.7 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $192,030 - $216,633	-751 Reduced 0.5%	150,491 $43.3 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $319,447 - $396,603	-1,461 Reduced 0.96%	151,242 $40.6 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $1.5 Million - $1.78 Million	7,013 Added 4.81%	152,703 $33.9 Million
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $14,450 - $17,612	-64 Reduced 0.04%	145,690 $35.2 Million

Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $124,821 - $158,600	545 Added 0.38%	145,754 $38.3 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $1.71 Million - $1.93 Million	-7,610 Reduced 4.98%	145,209 $32.7 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $401,666 - $446,984	-1,741 Reduced 1.13%	152,819 $37.2 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $211,376 - $233,837	-964 Reduced 0.62%	154,560 $37.4 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $934,139 - $1.07 Million	-4,697 Reduced 2.93%	155,524 $35 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $339,419 - $397,671	-1,599 Reduced 0.99%	160,221 $34.1 Million
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $522,518 - $579,696	-2,237 Reduced 1.36%	161,820 $39.4 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $1.09 Million - $1.28 Million	-4,932 Reduced 2.92%	164,057 $40.8 Million
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $2.14 Million - $2.55 Million	-9,909 Reduced 5.54%	168,989 $38.9 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $9.47 Million - $10.5 Million	40,348 Added 29.12%	178,898 $45.5 Million
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $6.27 Million - $7.7 Million	31,716 Added 29.69%	138,550 $32.7 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $863,453 - $1.15 Million	-4,738 Reduced 4.25%	106,834 $21.7 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $77,008 - $98,982	-407 Reduced 0.36%	111,572 $26.9 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $700,966 - $839,904	-4,026 Reduced 3.47%	111,979 $21.7 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $580,616 - $680,613	-3,483 Reduced 2.91%	116,005 $21.4 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $2.07 Million - $2.33 Million	-11,438 Reduced 8.74%	119,488 $22.7 Million
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $5.26 Million - $6.14 Million	-29,503 Reduced 18.39%	130,926 $25.5 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $592,742 - $668,239	-3,199 Reduced 1.96%	160,429 $33.3 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $1.69 Million - $1.9 Million	-10,190 Reduced 5.86%	163,628 $30.2 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $3.54 Million - $4.14 Million	-20,900 Reduced 10.73%	173,818 $29.6 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $2.34 Million - $2.61 Million	13,836 Added 7.65%	194,718 $33.9 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $30.3 Million - $34.5 Million	180,882	180,882 $33.7 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Amgen Inc Transaction History